The latest price target for Aemetis (NASDAQ:AMTX) was reported by Ascendiant Capital on May 22, 2026. The analyst firm set a price target for $22.00 expecting AMTX to rise to within 12 months (a possible 1253.85% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Aemetis (NASDAQ:AMTX) was provided by Ascendiant Capital, and Aemetis maintained their buy rating.

The last upgrade for Aemetis Inc happened on August 16, 2023 when UBS raised their price target to $10.5. UBS previously had a neutral for Aemetis Inc.

There is no last downgrade for Aemetis.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aemetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aemetis was filed on May 22, 2026 so you should expect the next rating to be made available sometime around May 22, 2027.

While ratings are subjective and will change, the latest Aemetis (AMTX) rating was a maintained with a price target of $21.00 to $22.00. The current price Aemetis (AMTX) is trading at is $1.63, which is out of the analyst’s predicted range.